Studies of an oral iron chelator: 1,2 ‐dimethyl‐ 3 ‐hydroxy‐pyrid‐4‐one I. IRON EXCRETION IN RATS: DEVELOPMENT OF A NEW RAPID MICROWAVE METHOD FOR IRON ANALYSIS IN FAECES
- 31 May 1990
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 75 (2) , 274-277
- https://doi.org/10.1111/j.1365-2141.1990.tb02662.x
Abstract
We have developed a simple, rapid method for analysing faecal iron using a microwave oven for digestion followed by atomic absorption spectrometry. The chelating effect of 1,2-dimethyl-3-hydroxy-pyrid-4-one (DMHP) has been tested in rats with experimental iron overloading and three routes of DHMP administration, oral, subcutaneous, and intraperitoneal, have been compared. Regardless of the route of administration, we have found that DHMP promotes iron excretion via the urine. We have not observed a difference in the amount of iron excreted in the faeces before and after DMHP administration by any route. The subcutaneous route of administration is the most effective in promoting iron excretion, followed by the intraperitoneal route. Although most convenient for clinical use, oral administration promotes the excretion of only a small fraction of that by the subcutaneous route.Keywords
This publication has 13 references indexed in Scilit:
- Dose response studies using desferrioxamine and orally active chelators in a mouse modelScandinavian Journal of Haematology, 2009
- Rapid sample preparation for determination of iron in tissue by closed-vessel digestion and microwave energy.Clinical Chemistry, 1988
- Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.BMJ, 1987
- Simple synthesis of the potent iron chelators 1-alkyl-3-hydroxy-2-methylpyrid-4-onesInorganica Chimica Acta, 1987
- Iron chelation studies using desferrioxamine and the potential oral chelator, 1,2-dimethyl-3-hydroxypyrid-4-one, in normal and iron loaded rats.Journal of Clinical Pathology, 1987
- Orally active α-ketohydroxy pyridine iron chelators intended for clinical use: in vivo studies in rabbitsBritish Journal of Haematology, 1986
- NEW ORALLY ACTIVE IRON CHELATORSThe Lancet, 1985
- Enhanced iron removal from liver parenchymal cells in experimental iron overload: liposome encapsulation of HBED and phenobarbital administrationBlood, 1983
- Liposome‐encapsulated Desferrioxamine in Experimental Iron OverloadBritish Journal of Haematology, 1981